This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Study of CPI-613 for Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-Grade B-Cell Lymphoma With High-Risk Translocations | MicrobiomeTrials
← Back to trials NCT03793140
A Study of CPI-613 for Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-Grade B-Cell Lymphoma With High-Risk Translocations Completed PHASE2 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2018-12-31Est. Completion: 2026-08-25
Enrollment target: 24 participantsLocations City of Hope, Duarte, California, United States Massachusetts General Hospital, Boston, Massachusetts, United States Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States Memorial Sloan Kettering Commack, Commack, New York, United States Memorial Sloan Kettering Westchester, East White Plains, New York, United States Memorial Sloan Kettering Cancer Center, New York, New York, United States Memorial Sloan Kettering Nassau, Uniondale, New York, United States University of Pennsylvania (Data Collection Only), Philadelphia, Pennsylvania, United States Md Anderson Cancer Center, Houston, Texas, United States Other microbiome trials you might be interested in Acute Lymphoblastic Leukemia, Pediatric
The study aims to conduct a real-world investigation of children with Philadelphia chromosome-positive acute lymphoblast…
Hangzhou, China Est. completion Sep 2026
ARDS (Moderate or Severe)
To verify whether the transpulmonary pressure-guided mechanical ventilation strategy can reduce right ventricular involv…
Beijing, China Est. completion Mar 31, 2028
Recruiting
Acute Leukemia Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Acute Biphenotypic Leukemia Acute Undifferentiated Leukemia CLL (Chronic Lymphocytic Leukemia) Chronic Myeloid Leukemia (CML) MDS (Myelodysplastic Syndrome) Non-Hodgkin Lymphomas Hodgkins Lymphoma Cutaneous T Cell Lymphomas (CTCL)
The goal of this clinical trial is to determine the safety and feasibility of allogeneic transplantation with bone marro…
Duarte, United States Est. completion Jul 14, 2026